Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospec…

Jason Hafron

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

Robot-assisted Radical Prostatectomy (RARP)

Bernardo Rocco

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

Year in Review: Cutting Edge Advances in Kidney Cancer - Imaging and…

Ketan Badani

Year in Review - Prostate Cancer

Oncology 2024 Year in Review

K. Tawagi

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

Advanced Prostate Cancer Consensus Conference (APCCC)

K. Fizazi

Year in Review 2024 - Bladder Cancer

Oncology 2024 Year in Review

G. Sonpavde

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

Advances in Prostate Cancer Surgery

Penn Medicine Abramson Cancer Center

B. Schurhamer, T. Guzzo

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

Year in Review 2024 - Renal Cell Carcinoma

Oncology 2024 Year in Review

N. Mar

Avoiding Unnecessary Operations in Prostate Cancer

Penn Medicine Abramson Cancer Center

P. Pierorazio

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

Evolving Strategies in First and Second-Line Treatment for mCRPC

International Urology Cancer Summit - IUCS

N. Agarwal

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

Year in Review: Bladder Cancer - 2024 Insights and Exciting Prospect…

Jason Hafron